| GA20034-25mg |
|
25255-33-8 |
(Arg⁸)-Vasopressin (free acid)
|
0 |
C46H64N14O13S2 |
|
|
|
| GA20034-5mg |
|
25255-33-8 |
(Arg⁸)-Vasopressin (free acid)
|
0 |
C46H64N14O13S2 |
|
|
|
| GA20033-25mg |
|
96027-30-4 |
|
0 |
C25H44N12O8S |
|
|
|
| GA20033-5mg |
|
96027-30-4 |
|
0 |
C25H44N12O8S |
|
|
|
| GA20032-5mg |
|
130836-24-7 |
|
0 |
C44H71N17O10S2 |
|
|
|
| GA20032-1mg |
|
130836-24-7 |
|
0 |
C44H71N17O10S2 |
|
|
|
| GA20031-1mg |
|
132956-87-7 |
(Arg⁶,β-cyclohexyl-Ala⁸,D-Tic¹⁶,Arg¹⁷,Cys¹⁸)-Atrial Natriuretic Factor (6-18) amide (mouse, rabbit, rat)
|
0 |
C69H116N26O15S2 |
|
|
|
| GA20031-005mg |
|
132956-87-7 |
(Arg⁶,β-cyclohexyl-Ala⁸,D-Tic¹⁶,Arg¹⁷,Cys¹⁸)-Atrial Natriuretic Factor (6-18) amide (mouse, rabbit, rat)
|
0 |
C69H116N26O15S2 |
|
|
|
| GA20030-1mg |
|
1802084-26-9 |
(Arg⁶)-Amyloid β-Protein (1-40)
|
0 |
C194H300N54O58S |
|
|
|
| GA20030-005mg |
|
1802084-26-9 |
(Arg⁶)-Amyloid β-Protein (1-40)
|
0 |
C194H300N54O58S |
|
|
|
| GA20029-1mg |
|
1816939-33-9 |
(Arg¹³)-Amyloid β-Protein (1-40)
|
0 |
C194H300N54O58S |
|
|
|
| GA20029-005mg |
|
1816939-33-9 |
(Arg¹³)-Amyloid β-Protein (1-40)
|
0 |
C194H300N54O58S |
|
|
|
| GA20028-100mg |
|
60284-47-1 |
|
0 |
C29H39N5O7 |
|
|
|
| GA20028-25mg |
|
60284-47-1 |
|
0 |
C29H39N5O7 |
|
|
|
| GA20027-1mg |
|
2243207-08-9 |
(Ala²)-Endothelin-3 (human, mouse, rabbit, rat)
|
0 |
C120H166N26O32S4 |
|
|
|
| GA20027-005mg |
|
2243207-08-9 |
(Ala²)-Endothelin-3 (human, mouse, rabbit, rat)
|
0 |
C120H166N26O32S4 |
|
|
|
| GA20026-1g |
|
32381-28-5 |
|
0 |
C12H20N2O6S2 |
|
|
|
| GA20025-5g |
|
62935-72-2 |
(7-Methoxycoumarin-4-yl)acetic acid
|
0 |
C12H10O5 |
|
|
|
| GA20025-1g |
|
62935-72-2 |
(7-Methoxycoumarin-4-yl)acetic acid
|
0 |
C12H10O5 |
|
|
|
| GA20024-1mg |
|
1802087-66-6 |
(7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40)
|
0 |
C208H308N54O61S |
|
|
|
